Meta-analysis on the effect of dopexamine on in-hospital mortality

Anaesthesia

Volumn 64, Issue 6, 2009, Pages 589-594

  Gopal, Shameer ^a   Jayakumar, D ^a   Nelson, P N ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPEXAMINE; PLACEBO;

ABDOMINAL SURGERY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE INCREASE; HUMAN; LOW DRUG DOSE; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; UROLOGICAL PROCEDURES;

ADRENERGIC BETA-AGONISTS; CRITICAL CARE; DATA INTERPRETATION, STATISTICAL; DOPAMINE; HOSPITAL MORTALITY; HUMANS; PERIOPERATIVE CARE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 66349098714     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2009.05896.x     Document Type: Article

References (19)

1. McGinley J, Lynch L, Hubbard K, McCoy D, Cunningham AJ. Dopexamine hydrochloride does not modify hemodynamic response or tissue oxygenation or gut permeability during abdominal aortic surgery. Canadian Journal of Anesthesia 2001; 48: 238-244 (Pubitemid 32303376)
2. Baguneid MS, Welsh M, Bukhari M, et al. A randomised study to evaluate the effect of a perioperative infusion of dopexamine on colonic mucosal ischaemia after aortic surgery. Journal of Vascular Surgery 2001; 33: 758-763 (Pubitemid 33586629)
3. Byers RJ, Eddleston JM, Pearson RC, Bigley G, McMahon RFT. Dopexamine reduces the incidence of acute inflammation in the gut mucosa after abdominal surgery in high-risk patients. Critical Care Medicine 1999; 27: 1787-1793 (Pubitemid 29455105)
4. Renton MC, Snowden CP. Dopexamine and its role in the protection of hepatosplanchnic and renal perfusion in high-risk surgical and critically ill patients. British Journal of Anaesthesia 2005; 94: 459-467 (Pubitemid 40500529)
5. Pearse RM, Belsey JD, Cole JN, Bennett ED. Effect of dopexamine infusion on mortality following major surgery: individual patient data meta-regression analysis of published clinical trials. Critical Care Medicine 2008; 36: 1323-1329
6. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996; 17: 1-12.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7: 177-188 (Pubitemid 17189972)
8. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Annals of Internal Medicine 2005; 142: 510-524 (Pubitemid 40490917)
9. Leandro G. Meta-Analysis in Medical Research, 1st edn, Oxford: Blackwell Publishing Limited, 2005.
10. Egger M, Smith GD. Meta-analysis bias in location and selection of studies. British Medical Journal 1998; 316: 61-66 (Pubitemid 28019876)
11. Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. Journal of the American Medical Association 1993; 270: 2699-2707 (Pubitemid 23350967)
12. Stone MD, Wilson RJT, Cross J, Williams BT. Effect of adding dopexamine to intra-operative volume expansion in patients undergoing major elective abdominal surgery. British Journal of Anaesthesia 2003; 91: 619-624 (Pubitemid 37369520)
13. Takala J, Meier Hellmann A, Eddleston J, Hulstaert P, Sramek V, for the European Multicenter Study Group on Dopexamine in Major Abdominal Surgery. Effect of dopexamine on outcome after major abdominal surgery: a prospective, randomized, controlled multicenter study. Critical Care Medicine 2000; 28: 3417-3423
14. Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. British Medical Journal 1999; 318: 1099-1103 (Pubitemid 29192147)
15. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett D. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial. Critical Care 2005; 9: R687- 93.
16. Ralph CJ, Tanser SJ, Macnaughton PD, et al. A randomised controlled trial investigating the effects of dopexamine on gastrointestinal function and organ dysfunction in the critically ill. Intensive Care Medicine 2002; 28: 884-890 (Pubitemid 34762223)
17. Thompson SG. Why sources of heterogeneity in metaanalysis should be investigated. British Medical Journal 1994; 309: 1351-1355 (Pubitemid 24345976)
18. Lyman GH, Kuderer NM. The strengths and limitation of meta-analyses based on aggregate data. Biomed Central Medical Research Methodology 2005; 5: 14. (Pubitemid 40918747)
19. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. British Medical Journal. 2006; 333: 420-425 (Pubitemid 44320127)